ado heating up in august, page-6

yes, any IVD siging would be huge.. any other minor siging with pay the bills.

These IVD companies do their due diligence and rigorous testing, as it is quite likely that once they adopt the technology, they will roll it out across all their immunoassays. For the bigger IVD companies, that would mean $20-30 mil pa revenue plus. For larger second tier, maybe half that figure. That's probably why Geoff is so optimistic, let alone ds.

When it rains.. it certainly will pour. $1 within 3-4 years is not inconceivable.